Our partners at Citeline have just released the report Raise Awareness for Parkinson’s Drug Development on Moving Day®. Moving Day, supported by the National Parkinsons Foundation, it is a day to promote awareness, generate funding for research and educate the general public about the disease. In the paper, Laurie Withington, PhD., Senior Analyst, Central Nervous, System Diseases, Citeline, looks at the 33 drugs that are in the late stage development to treat the disease. Most of these drugs are in the late stage of reformulation of already approved Parkinsons Disease.
Below is an infographic showing the later stages of drug development of Parkinsons Disease:
To see more including the companies who are bringing the best options to the Parkinsons Disease treatment pipeline, download the full Citeline report.